The National Institute for Health and Care Excellence recommended nivolumab , a type of immunotherapy which stimulates the body’s immune system to fight cancer cells. Nivolumab targets and blocks a protein called PD-1 on the surface of certain immune cells called T-cells.
Are you up for a challenge?
